Background It is evident that nosocomial yeast infections have become a serious clinical
entity with high morbidity and mortality among immunosuppressed patients. The increasing
reports of Candida and non-Candida yeasts in this population are caused primarily by the
improvement in the management of patients in the fields of oncology, critical care, and
transplantation. In no small part, Candida species is responsible for approximately three
quarters of these infections. The factors associated with the increased rate of yeast infections …